trial · primary record
Lenbelintide
Obesity or Overweight
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 2500 |
| Primary completion | 2029-05-21 |
| Primary endpoint | Percent change in body weight from baseline at 68 weeks of treatment |
| Registry ID | NCT07784725 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:13.757Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07784725
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Lenbelintide · compound